810223C

C12-NBD Glucosyl Ceramide

Avanti Research^™ - A Croda Brand 810223C

• 同義詞: N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-glucosyl-β1-1′-sphingosine
• 經驗公式（希爾表示法）: C₄₂H₇₁N₅O₁₁
• CAS號碼: 474943-01-6
• 分子量：: 822.04
• 分類程式碼代碼: 12352211
• NACRES: NA.25

屬性

• 化驗: >99% (TLC)
• 形狀: liquid
• 包裝: pkg of 1 × 1 mL (810223C-250ug)
• 製造商／商標名: Avanti Research^™ - A Croda Brand 810223C
• 濃度: 0.25 mg/mL (810223C-250ug)
• 運輸包裝: dry ice
• 儲存溫度: −20°C

描述

應用

C12-NBD Glucosyl Ceramide is suitable for liposome preparation.

生化／生理作用

Glucosyl ceramide (GlcCer) is produced by GlcCer synthase from ceramide in the cytosolic membranes of Golgi. In the luminal Golgi membrane, GlcCer participates in the generation of glycosphingolipids.

包裝

5 mL Amber Glass Screw Cap Vial (810223C-250ug)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全資訊

• 象形圖: GHS06,GHS08
• 訊號詞: Danger
• 危險聲明: H302,H315,H319,H331,H336,H351,H361d,H372
• 防範說明: P201 - P260 - P264 - P280 - P304 + P340 + P311 - P403 + P233
• 危險分類: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• 標靶器官: Central nervous system
• 水污染物質分類（WGK）: WGK 3